Genetics Study of In-stent Restenosis (ISR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01670396 |
Recruitment Status : Unknown
Verified August 2012 by Shanghai Zhongshan Hospital.
Recruitment status was: Recruiting
First Posted : August 22, 2012
Last Update Posted : August 22, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Coronary Artery Disease |
Study Type : | Observational |
Estimated Enrollment : | 300 participants |
Observational Model: | Case-Control |
Time Perspective: | Retrospective |
Official Title: | G Protein β3 Subunit (GNB3) Polymorphism and Restenosis of Coronary Drug-eluting Stents |
Study Start Date : | March 2012 |
Estimated Primary Completion Date : | August 2012 |
Estimated Study Completion Date : | September 2012 |
Group/Cohort |
---|
in-stent restenosis |
non-in-stent restenosis |
- In-stent restenosis [ Time Frame: 6-24months after stent implanting ]
- target lesion revascularization (TLR) [ Time Frame: 6-24months after stent implanting ]
- re-myocardial infarction [ Time Frame: 6-24months after stent implating ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients who underwent follow-up angiography. All the patients must had been implanted with DES during the last two years.
Exclusion Criteria:
- For the non-ISR group, the patients underwent follow-up angiography less than 6 months away from stent implanting.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01670396
Contact: Yamei Xu | 8613917133371 | xu.yamei@zs-hospital.sh.cn |
China | |
Zhongshan Hospital | Recruiting |
Shanghai, China | |
Contact: Yamei Xu 8613917133371 xu.yamei@zs-hospital.sh.cn |
Responsible Party: | Shanghai Zhongshan Hospital |
ClinicalTrials.gov Identifier: | NCT01670396 |
Other Study ID Numbers: |
ZS-XN-ISR |
First Posted: | August 22, 2012 Key Record Dates |
Last Update Posted: | August 22, 2012 |
Last Verified: | August 2012 |
coronary stent implant polymorphism G protein drug-eluting stent restenosis |
Coronary Artery Disease Coronary Disease Myocardial Ischemia Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |